UBT251 lowered blood sugar in adults with type 2 diabetes
Glycated hemoglobin, a long-term blood sugar measure, fell 1.98 to 2.16 percentage points with UBT251, versus 1.77 with semaglutide and 0.66 with placebo at 24 weeks.Glycated hemoglobin, a long-term blood sugar measure, fell 1.98 to 2.16 percentage points with UBT251, versus 1.77 with semaglutide and 0.66 with placebo at 24 weeks.